Detailed information for compound 1087047

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 417.972 | Formula: C23H32ClN3O2
  • H donors: 1 H acceptors: 1 LogP: 5.57 Rotable bonds: 10
    Rule of 5 violations (Lipinski): 1
  • SMILES: CCCCCCn1c(=N)n(c2c1cccc2)CC(COc1ccccc1C)O.Cl
  • InChi: 1S/C23H31N3O2.ClH/c1-3-4-5-10-15-25-20-12-7-8-13-21(20)26(23(25)24)16-19(27)17-28-22-14-9-6-11-18(22)2;/h6-9,11-14,19,24,27H,3-5,10,15-17H2,1-2H3;1H
  • InChiKey: BKCZSVGWRIKPEN-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Giardia lamblia Kinesin-5 0.0356112 0.131062 0.5
Echinococcus granulosus kinesin family 1 0.269633 1 1
Plasmodium vivax kinesin-5 0.0356112 0.131062 0.5
Loa Loa (eye worm) kinesin-like protein KLP2 0.0356112 0.131062 1
Schistosoma mansoni kinesin eg-5 0.0356112 0.131062 0.151033
Entamoeba histolytica kinesin, putative 0.0356112 0.131062 0.5
Plasmodium falciparum kinesin-5 0.0356112 0.131062 0.5
Echinococcus multilocularis kinesin family 1 0.269633 1 1
Toxoplasma gondii kinesin motor domain-containing protein 0.0356112 0.131062 0.5
Brugia malayi Kinesin motor domain containing protein 0.0356112 0.131062 1
Schistosoma mansoni hypothetical protein 0.234021 0.867773 1

Activities

Activity type Activity value Assay description Source Reference
EC50 (functional) 0.7152 uM ST_JUDE: Plasmodium falciparum K1 EC50 (uM) as measured by SYBR green dye ChEMBL. 20485428
EC50 (functional) 1.1138 uM ST_JUDE: Cytotoxicity against Plasmodium falciparum Dd2 ChEMBL. 20485428
EC50 (functional) 1.262 uM ST_JUDE: Plasmodium falciparum 3D7 EC50 (uM) as measured by SYBR green dye ChEMBL. 20485428
EC50 (functional) 1.2863 uM ST_JUDE: Cytotoxicity against Plasmodium falciparum W2 ChEMBL. 20485428
EC50 (functional) 1.4288 uM ST_JUDE: Cytotoxicity against Plasmodium falciparum K1 ChEMBL. 20485428
EC50 (functional) 2.0937 uM ST_JUDE: Cytotoxicity against Plasmodium falciparum V1/S ChEMBL. 20485428
EC50 (functional) 2.1973 uM ST_JUDE: Cytotoxicity against Plasmodium falciparum 3D7 ChEMBL. 20485428
EC50 (functional) 3.7254 uM ST_JUDE: Cytotoxicity using luciferase to measure ATP as an indicator of the viability of Trypanosoma brucei ChEMBL. 20485428
EC50 (functional) 4.6662 uM ST_JUDE: Cytotoxicity against Plasmodium falciparum SB-A6 ChEMBL. 20485428
EC50 (functional) 6.5698 uM ST_JUDE: Cytotoxicity against Plasmodium falciparum D10 transfected with yeast DHOD ChEMBL. 20485428
EC50 6.9776 uM ST_JUDE: Cytotoxicity using luciferase to measure ATP as an indicator of the viability of human epithelial hepatocellular carcinoma cells (HepG2) ChEMBL. 20485428
EC50 12.6142 uM ST_JUDE: Cytotoxicity using luciferase to measure ATP as an indicator of the viability of human Burkitt''s lymphoma lymphoblast cells (Raji) ChEMBL. 20485428
EC50 (functional) 13.8577 uM ST_JUDE: Growth inhibition of to Toxoplasma gondii, in human U-2OS cells, as measured by luciferase. ChEMBL. 20485428
EC50 16.8339 uM ST_JUDE: Cytotoxicity using luciferase to measure ATP as an indicator of the viability of human foreskin fibroblast cells (BJ) ChEMBL. 20485428
EC50 20.2776 uM ST_JUDE: Cytotoxicity using luciferase to measure ATP as an indicator of the viability of human epithelial embryonic kidney cells (HEK293) ChEMBL. 20485428
EC50 (functional) > 23.4 uM ST_JUDE: Cytotoxicity using Alamar Blue to measure viability of Leishmania major ChEMBL. 20485428

Phenotypes

Whole-cell/tissue/organism interactions

Species name Source Reference Is orphan
Trypanosoma brucei gambiense 20485428
Toxoplasma gondii ChEMBL23 20485428
Plasmodium falciparum ChEMBL23 20485428
Trypanosoma brucei ChEMBL23 20485428
Homo sapiens ChEMBL23 20485428

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.